CureVac (CVAC) News Today $5.46 +0.01 (+0.18%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$5.46 0.00 (0.00%) As of 07/11/2025 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CVAC Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period CVAC - CureVac NV Ordinary Shares Key Metrics - MorningstarJuly 9 at 9:21 PM | morningstar.comMCureVac (NASDAQ:CVAC) Trading Down 0.1% - What's Next?July 5, 2025 | marketbeat.comUBS Downgrades CureVac N.V. (CVAC)June 27, 2025 | msn.comUBS Group Reiterates Neutral Rating for CureVac (NASDAQ:CVAC)June 26, 2025 | marketbeat.com$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of CureVac N.V. (NASDAQ: CVAC)June 20, 2025 | globenewswire.comBioNTech SE Announces Acquisition of CureVac N.V.June 17, 2025 | tipranks.comM&A News: BioNTech Snaps Up CureVac in $1.25B Deal to Supercharge Cancer PipelineJune 14, 2025 | theglobeandmail.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, KNW, SOAR, HLGN on Behalf of ShareholdersJune 13, 2025 | globenewswire.comCureVac (NASDAQ:CVAC) Earns "Hold" Rating from Jefferies Financial GroupJune 13, 2025 | marketbeat.comCureVac stock soars about 30% after BioNTech agrees to acquire coJune 13, 2025 | finance.yahoo.comCureVac (NASDAQ:CVAC) Sets New 52-Week High - Time to Buy?June 13, 2025 | marketbeat.comBioNTech Announces Strategic Acquisition of CureVacJune 12, 2025 | tipranks.comBioNTech to Acquire CureVac in Strategic mRNA ExpansionJune 12, 2025 | tipranks.comBioNTech (BNTX) to Acquire CureVac for $1.25 Billion | BNTX Stock NewsJune 12, 2025 | gurufocus.comCureVac (NASDAQ:CVAC) Shares Gap Up - Time to Buy?June 12, 2025 | marketbeat.comCureVac Sees Unusually High Options Volume (NASDAQ:CVAC)June 12, 2025 | marketbeat.comBioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock DealJune 12, 2025 | benzinga.comTop Stock Movers Now: Oracle, Boeing, CureVac, and MoreJune 12, 2025 | investopedia.comM&A News: BioNTech (BNTX) Acquires CureVac in $1.25 Billion DealJune 12, 2025 | tipranks.comCureVac, TELUS International, Oracle And Other Big Stocks Moving Higher On ThursdayJune 12, 2025 | benzinga.comBioNTech boosts cancer mRNA pipeline with CureVac acquisitionJune 12, 2025 | proactiveinvestors.comCVAC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CureVac N.V. Is Fair to ShareholdersJune 12, 2025 | businesswire.comBioNTech to Acquire CureVac in Strategic Move to Advance mRNA Cancer Immunotherapy InitiativesJune 12, 2025 | quiverquant.comQBioNTech to Buy CureVac in $1.25 Billion Deal. Both Stocks Are Rising.June 12, 2025 | barrons.comBioNTech to acquire CureVac in $1.25 billion all-stock dealJune 12, 2025 | reuters.comTwo Sigma Investments LP Invests $391,000 in CureVac (NASDAQ:CVAC)June 11, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Trading Down 5% - Here's WhyJune 10, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Trading Down 4.7% - Here's What HappenedJune 4, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Shares Gap Up - Here's What HappenedJune 3, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Trading Up 5.3% - Time to Buy?May 30, 2025 | marketbeat.comJMP Securities Reaffirms "Market Outperform" Rating for CureVac (NASDAQ:CVAC)May 29, 2025 | marketbeat.comMillennium Management LLC Sells 771,136 Shares of CureVac (NASDAQ:CVAC)May 29, 2025 | marketbeat.comWe Think CureVac's (NASDAQ:CVAC) Robust Earnings Are ConservativeMay 27, 2025 | finance.yahoo.comBNP Paribas Financial Markets Takes $585,000 Position in CureVac (NASDAQ:CVAC)May 26, 2025 | marketbeat.comFY2025 EPS Estimates for CureVac Boosted by Leerink PartnrsMay 25, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Shares Sold by Point72 Asset Management L.P.May 24, 2025 | marketbeat.comEarnings Beat: CureVac N.V. (NASDAQ:CVAC) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their ForecastsMay 23, 2025 | finance.yahoo.comCureVac (NASDAQ:CVAC) Shares Gap Down - Here's WhyMay 23, 2025 | marketbeat.comCautious Hold Rating for CureVac Amid Uncertain Revenue ProjectionsMay 23, 2025 | tipranks.comCureVac N.V. Reports Q1 2025 Financial Results Amid Strategic RestructuringMay 20, 2025 | tipranks.comCureVac (CVAC) Stock Rises After Q1 Update, Oncology Pipeline Gains TractionMay 20, 2025 | benzinga.comCureVac (CVAC) to Release Earnings on ThursdayMay 17, 2025 | marketbeat.comBioNTech (BNTX) Faces Ongoing Patent Challenge with CureVac | BNTX Stock NewsMay 15, 2025 | gurufocus.comAlyeska Investment Group L.P. Grows Stake in CureVac (NASDAQ:CVAC)May 9, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Shares Gap Up - Should You Buy?May 5, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Price Target Lowered to $12.00 at UBS GroupMay 2, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Shares Up 7.7% - Still a Buy?April 30, 2025 | marketbeat.comCureVac (CVAC) Target Price Reduced by UBS Analyst | CVAC Stock NewsApril 30, 2025 | gurufocus.comCureVac (NASDAQ:CVAC) Shares Gap Up - Here's WhyApril 27, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Sees Significant Increase in Short InterestApril 23, 2025 | marketbeat.com Get CureVac News Delivered to You Automatically Sign up to receive the latest news and ratings for CVAC and its competitors with MarketBeat's FREE daily newsletter. Email Address CVAC Media Mentions By Week CVAC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CVAC News Sentiment▼1.061.00▲Average Medical News Sentiment CVAC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CVAC Articles This Week▼23▲CVAC Articles Average Week Get CureVac News Delivered to You Automatically Sign up to receive the latest news and ratings for CVAC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CRSP News Today ADMA News Today PCVX News Today RYTM News Today CYTK News Today KRYS News Today AKRO News Today ZLAB News Today PTCT News Today RARE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CVAC) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CureVac N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share CureVac With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.